Novo and Hims End Dispute to Partner on Obesity Drugs
Novo Nordisk will sell weight-loss drugs on the Hims & Hers platform to end a legal battle. A formal partnership announcement is expected this coming Monday.
Xurve View
Insights:
Xurve View
The Danish pharmaceutical company Novo Nordisk A/S and the digital health provider Hims & Hers Health, Inc. have reportedly resolved their legal dispute and entered into a partnership to distribute weight-loss treatments. This agreement brings an end to a conflict that escalated into a lawsuit last month, according to a Bloomberg News report published on Friday.
